ORMP ORAMED PHARMACEUTICALS INC Other Situations 8-K Filing 2023 - Acquisition Agreement Terminated and New Securities Purchase Agreement Established Oramed Pharmaceuticals Inc. terminated a Stock Purchase Agreement with Sorrento Therapeutics and entered into a Securities Purchase Agreement with Scilex Holding Company, acquiring certain equity securities for $105 million.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC